Arkolith/Insider Trading/OLMA/Form 4

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFFOlema Pharmaceuticals, Inc. (OLMA) · full profile →Form 4 · filed Dec 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2025Gift(G)9K—$0543K
Dec 19, 2025Sell(S)6K$31.39$190K552K
Dec 19, 2025Sell(S)44K$30.40$1.3M558K
Dec 19, 2025Sell(S)1K$28.08$34K602K

Transaction Codes

G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001831216-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML